What’s New in PAD: Factor Xa Inhibitors and Antiplatelet Postprocedure

The goals of this activity are to inform participants about the latest clinical data regarding factor Xa inhibitor therapy in patients with peripheral artery disease (PAD) and to improve the use of antithrombotic therapy in patients with PAD who have undergone recent peripheral revascularization.
 
Educational Partner: Medscape, LLC
 
Medium: Online Presentation
 
Commercial Support: This activity is supported by an independent educational grant from Janssen Pharmaceuticals, Inc.

Target Audience

This activity is intended for cardiologists, primary care physicians, and surgeons, as well as all healthcare providers who care for patients at risk of PAD.

Learning Objectives

Upon completion of this activity, participants will:
 
  • Have increased knowledge regarding the
    • Clinical burden of PAD;
    • Latest data on treatment options for patients with PAD following a revascularization procedure.
Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
For more information, please contact:
CME Coordinator Contact Name: 
Medscape
CME Coordinator Contact Email: 
Summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
Activity opens: 
04/30/2020
Activity expires: 
04/30/2021
FACULTY
Marc P. Bonaca, MD, MPH
Associate Professor of Medicine
Director of Vascular Research
University of Colorado School of Medicine
Executive Director
The CPC
Aurora, Colorado
 
William R. Hiatt, MD
Professor of Medicine/Cardiology
University of Colorado School of Medicine
Chief Science Officer, CPC Clinical Research
Aurora, Colorado
COURSE REVIEWER
Matthew Sorrentino, MD, FACC, FAHA
Vice Chair for Clinical Operations
Department of Medicine
Section of Cardiology
University of Chicago Medicine
 
 

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Accreditation Statements
 
Developed through a collaboration between the University of Chicago Medicine and Medscape Education.
 
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Other Healthcare Professions Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Registration: To view this activity, you will need to visit Medscape's website.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!
 
Please login or create an account to proceed.